Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Tilray Inc Stock Research

TLRY

2.40USD-0.17(-6.61%)Market Closed
Watchlist

Market Summary

USD2.40-0.17
Market Closed
-6.61%

TLRY Stock Price

TLRY RSI Chart

TLRY Valuation

Market Cap

1.6B

Price/Earnings (Trailing)

-1.08

Price/Sales (Trailing)

2.51

EV/EBITDA

-0.94

Price/Free Cashflow

199.34

TLRY Price/Sales (Trailing)

TLRY Profitability

EBT Margin

-301.90%

Return on Equity

-52.65%

Return on Assets

-40.95%

Free Cashflow Yield

0.5%

TLRY Fundamentals

TLRY Revenue

Revenue (TTM)

627.1M

Revenue Y/Y

20.13%

Revenue Q/Q

26.51%

TLRY Earnings

Earnings (TTM)

-1.5B

Earnings Y/Y

70.99%

Earnings Q/Q

88.15%

Price Action

52 Week Range

2.285.12
(Low)(High)

Last 7 days

1.6%

Last 30 days

-7.7%

Last 90 days

-6.1%

Trailing 12 Months

-11.1%

TLRY Financial Health

Current Ratio

1.61

TLRY Investor Care

Diluted EPS (TTM)

-2.35

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for TLRY

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-07-31
FALTISCHEK DENISE M
sold (taxes)
-242,624
2.53
-95,899
chief strategy officer
2023-07-31
Merton Carl A
acquired
475,266
2.53
187,852
chief financial officer
2023-07-31
FALTISCHEK DENISE M
acquired
475,266
2.53
187,852
chief strategy officer
2023-07-31
Merton Carl A
sold (taxes)
-238,394
2.53
-94,227
chief financial officer
2023-07-31
SIMON IRWIN D
sold (taxes)
-1,976,170
2.53
-781,094
president and ceo
2023-07-31
Gendel Mitchell
acquired
475,266
2.53
187,852
global general counsel
2023-07-31
Gendel Mitchell
sold (taxes)
-242,624
2.53
-95,899
global general counsel
2023-07-31
SIMON IRWIN D
acquired
3,573,440
2.53
1,412,430
president and ceo
2023-07-27
SIMON IRWIN D
sold (taxes)
-116,206
2.14
-54,302
president and ceo
2023-07-27
SIMON IRWIN D
acquired
210,131
2.14
98,192
president and ceo

1–10 of 50

Which funds bought or sold TLRY recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-21
Baystate Wealth Management LLC
added
15.15
-24.00
59.00
-%
2023-09-21
Halpern Financial, Inc.
unchanged
-
-5,690
9,151
-%
2023-09-20
BARCLAYS PLC
added
802
185,000
225,000
-%
2023-09-11
BLUEFIN CAPITAL MANAGEMENT, LLC
unchanged
-
-28,214
45,376
0.01%
2023-08-29
Garde Capital, Inc.
unchanged
-
-67,000
108,000
0.01%
2023-08-24
Alberta Investment Management Corp
unchanged
-
-528,381
830,845
0.01%
2023-08-23
Stonebridge Capital Advisors LLC
unchanged
-
-650
1,045
-%
2023-08-22
VIRGINIA RETIREMENT SYSTEMS ET AL
sold off
-100
-273,746
-
-%
2023-08-21
OSAIC HOLDINGS, INC.
reduced
-1.51
-372,068
577,664
-%
2023-08-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
added
7.74
-456,100
902,783
-%

1–10 of 40

Latest Funds Activity

Are funds buying TLRY calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own TLRY
No. of Funds

Schedule 13G FIlings of Tilray

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2023
hudson bay capital management lp
2.23%
14,006,029
SC 13G/A
May 25, 2021
kennedy brendan
2.9%
12,837,819
SC 13D/A
Feb 16, 2021
cvi investments, inc.
-
7,012,907
SC 13G/A
Feb 16, 2021
etf managers group, llc
4.08%
5,446,196
SC 13G/A
Feb 16, 2021
groh christian
229%
3,930,804
SC 13D/A
Feb 16, 2021
blue michael g.
906%
4,598,454
SC 13D/A
Feb 16, 2021
kennedy brendan
7.9%
12,782,843
SC 13D/A
Dec 07, 2020
etf managers group, llc
5.01%
6,690,462
SC 13G/A
Nov 16, 2020
etf managers group, llc
4.71%
6,282,498
SC 13G/A
Oct 16, 2020
kennedy brendan
10.1%
13,706,097
SC 13D/A

Recent SEC filings of Tilray

View All Filings
Date Filed Form Type Document
Sep 22, 2023
S-8
Employee Benefits Plan
Sep 15, 2023
PRE 14A
PRE 14A
Sep 01, 2023
8-K
Current Report
Aug 07, 2023
8-K
Current Report
Aug 02, 2023
4
Insider Trading
Aug 02, 2023
4
Insider Trading
Aug 02, 2023
4
Insider Trading
Aug 02, 2023
4
Insider Trading
Jul 28, 2023
4
Insider Trading
Jul 28, 2023
4
Insider Trading

Peers (Alternatives to Tilray)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
494.8B
29.5B
-0.66% 79.36%
76.16
16.77
1.53% 14.16%
413.2B
97.8B
-4.35% -2.72%
31.65
4.23
2.29% -28.92%
272.8B
58.3B
-4.37% 23.96%
17.88
4.63
2.00% -81.24%
182.9B
77.9B
-10.94% -25.44%
8.52
2.35
-23.04% -26.74%
150.1B
45.2B
-5.70% -15.91%
23.72
3.25
-4.15% 20.34%
MID-CAP
6.5B
-
1.99% 679.20%
-74.1
4.1K
-86.94% 71.24%
4.3B
4.6B
-16.08% -16.44%
-62.89
0.92
6.60% 42.04%
SMALL-CAP
1.6B
634.0M
-6.94% -10.23%
36.56
2.5
0.62% -24.59%
1.6B
627.1M
-7.75% -11.11%
-1.08
2.51
-0.20% -204.67%
858.4M
244.3M
-1.05% 13.25%
4.35
3.51
-39.50% -4.99%
804.1M
109.5M
24.85% -25.44%
-5.6
7.34
-2.66% -32.13%
507.6M
453.3M
136.46% -66.34%
-0.41
1.12
-16.04% 55.90%
469.2M
31.2M
-3.91% -52.16%
-4.46
15.05
407.54% -26.47%
255.1M
54.6M
-17.22% -39.02%
-2.81
4.67
9.39% -179.16%
-
2.2B
- -
-
-
-22.39% 63.59%

Tilray News

MarketBeat
Tilray (TLRY) to Release Quarterly Earnings on Wednesday.
MarketBeat,
6 hours ago
Proactive Investors USA
Investing.com Canada

Returns for TLRY

Cumulative Returns on TLRY

-55.1%


5-Year Cumulative Returns

-20.6%


3-Year Cumulative Returns

Risks for TLRY

What is the probability of a big loss on TLRY?

94.4%


Probability that Tilray stock will be more than 20% underwater in next one year

94%


Probability that Tilray stock will be more than 30% underwater in next one year.

91.6%


Probability that Tilray stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does TLRY drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Tilray was unfortunately bought at previous high price.

Drawdowns

Financials for Tilray

Income Statement (Last 12 Months)
Income Statement (Last 12 Months)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12021Q12020Q42020Q42020Q32020Q32020Q22020Q22020Q12020Q12019Q42019Q4
Revenue5.2%627,124,000596,261,000602,543,000613,560,000628,372,000617,283,000509,866,400445,466,000382,326,857345,396,000367,297,714339,356,000355,515,429314,798,000330,394,286302,939,500317,408,571278,758,286290,483,333234,016,000243,270,400
Gross Profit109.0%146,960,00070,306,000121,834,000114,476,000116,817,000146,048,000120,142,400112,891,33389,518,28678,071,00081,508,00074,466,00075,594,28630,906,00033,418,28629,972,50037,582,28628,705,71426,243,33312,580,66760,702,400
Operating Expenses-16.6%1,516,645,0001,817,434,000680,306,000676,686,000727,218,000362,713,000359,310,000332,258,000255,353,000-212,224,000-209,324,000-173,676,000-200,062,000----
  S&GA Expenses-1.7%34,840,00035,435,00037,624,00037,165,00034,926,00033,808,00032,848,80034,591,33326,576,00036,902,85736,560,66754,666,00042,444,00057,302,40061,628,00072,785,00018,975,00074,318,000-63,813,000-
  R&D Expenses22.7%682,000556,000549,000899,0001,518,0001,822,0002,389,6002,851,333830,0002,758,2862,416,6674,411,0002,612,0005,856,8006,400,0008,595,0001,916,0009,471,000-9,172,000-
EBITDA100.0%--1,800,097,000-434,078,000-360,604,000-285,803,000----281,969,000-333,431,333-235,365,000-235,365,000-286,204,800-385,096,000-472,522,000-479,614,000-65,459,000-442,407,000-289,806,000-289,806,000-110,328,000
EBITDA Margin100.0%--3.02-0.72-0.59-0.45----0.74-0.97-0.64-0.69-0.81-1.22-1.43-1.58-0.21-1.59-1.00-1.24-0.45
Earnings Before Taxes19.4%-1,450,181,000-1,800,097,000-542,889,000-469,415,000-440,674,00059,286,000-467,923,200-462,342,666-344,986,000-466,364,571-316,617,333-276,675,000-322,115,200-418,572,800-521,277,000-527,432,000-109,185,000-481,327,000--329,619,000-
EBT Margin100.0%--3.02-0.90-0.77-0.700.10-0.92-1.04-0.90-1.09-0.75-0.82-0.91-1.33-1.58-1.74-0.34-1.73-1.13--
Net Income18.9%-1,452,656,000-1,792,084,000-577,896,000-508,634,000-476,801,00048,544,000-487,296,000-474,510,666-403,872,000-461,386,000-332,466,857-251,712,000-285,986,857-312,860,500-356,231,428-311,924,500-309,806,857-280,776,000-204,823,333-217,067,333-85,162,400
Net Income Margin100.0%--3.01-0.96-0.83-0.760.08-0.96-1.07-1.07-1.35-0.92-0.74-0.80-0.99-1.08-1.03-0.98-1.00-0.70--
Free Cashflow100.0%--56,216,000-83,974,000-130,304,000-177,262,000-148,489,000-91,528,800-79,811,333-73,537,000-123,480,000-173,995,000-173,995,000-189,204,400-263,802,800-312,383,000-313,311,000-183,641,000-370,269,000-331,806,000--
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets-1.6%4,3074,3765,4745,5925,4505,4505,8195,7635,9866,0251,1689468878561,7389168961,0401,0241,077657
  Current Assets1.9%773759815911804804696708845884572347305290582339259331359400554
    Cash Equivalents25.2%20716519049141641627933237648841619015513736117497.00100185294487
  Inventory-1.1%20120324124524624627323325225697.0094.0090.0093.0014096.0088.0011075.0049.0016.00
  Net PPE-----587----651198200188176-18718416614812980.00
  Goodwill0.2%2,0092,0062,6212,6182,6412,6412,8353.002,8092,8331691671601564471601631635.00156-
Liabilities0.8%9779699911,0291,0081,0081,1581,2901,6011,560628572701724463725611624664695459
  Current Liabilities-7.8%43347042727328028028231552740128418113416412017192.0013017617026.00
  Short Term Borrowings29.0%23.0018.0015.0018.0018.0018.0017.009.009.009.00----0.00------
    LT Debt, Current----64.0068.00-70.0032.0031.0037.00----6.00------
    LT Debt, Non Current-----118-121152165167----94.00------
Shareholder's Equity-2.6%3,3163,4044,4834,5634,3994,3994,6614,4734,3864,4655413741871311,275190285416360382-
  Retained Earnings-6.1%-2,415-2,276-1,105-1,036-962-962-484-527-527-486-1,071-730-727-724-113-643-430-209-173-138-108
  Additional Paid-In Capital1.0%5,7785,7235,6975,6415,3825,3825,1114,9554,7964,7921,6001,0969118561,367840706623527516302
Shares Outstanding6.3%657618613601533533486460449446169126120125-10610098.0097.0095.0083.00
Minority Interest358.4%14.003.0013.0038.0043.0043.0034.0037.0066.006.00----27.00------
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12021Q12020Q42020Q42020Q32020Q32020Q22020Q22020Q12019Q42019Q32019Q2
Cashflow From Operations114.1%8.00-56.22-83.97-130-177-148-91.53-79.81-44.72-80.74-85.52-129-126-201-237-238-100-287-258-187-153
  Share Based Compensation2.2%40.0039.0038.0041.0036.0033.0027.0021.0017.0023.0022.0030.0026.0029.0028.0034.0018.0034.0032.0026.0029.00
Cashflow From Investing-0.9%-285-282-278-14.45-21.5333326034.0046.00-186-217-41.68-269-35.13-31.48-84.05-69.95-101-253-309-268
Cashflow From Financing-68.9%70.00226223260128-96.49180266124301195265253229242274131274115496581

TLRY Income Statement

2023-05-31
Consolidated Statements of Loss and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
May 31, 2023
May 31, 2022
May 31, 2021
Net revenue$ 627,124$ 628,372$ 513,085
Cost of goods sold480,164511,555389,903
Gross profit146,960116,817123,182
Operating expenses:   
General and administrative165,159162,801111,575
Selling34,84034,92626,576
Amortization93,489115,19135,221
Marketing and promotion30,93730,93417,539
Research and development6821,518830
Change in fair value of contingent consideration855(44,650)0
Impairments934,001378,2410
Other than temporary change in fair value of convertible notes receivable246,33000
Litigation (recovery) costs(505)16,5183,251
Restructuring costs9,2457950
Transaction costs1,61330,94460,361
Total operating expenses1,516,645727,218255,353
Operating loss(1,369,685)(610,401)(132,171)
Interest expense, net(13,587)(27,944)(27,977)
Non-operating income (expense), net(66,909)197,671(184,838)
Loss before income taxes(1,450,181)(440,674)(344,986)
Income tax benefits, net(7,181)(6,542)(8,972)
Net loss(1,443,000)(434,132)(336,014)
Total net income (loss) attributable to:   
Stockholders of Tilray Brands, Inc.(1,452,656)(476,801)(367,421)
Non-controlling interests9,65642,66931,407
Other comprehensive income (loss), net of tax   
Foreign currency translation gain (loss)(83,533)(125,306)156,649
Unrealized gain (loss) on convertible notes receivable75,177(71,428)(3,824)
Total other comprehensive income (loss), net of tax(8,356)(196,734)152,825
Comprehensive loss(1,451,356)(630,866)(183,189)
Total comprehensive income (loss) attributable to:   
Stockholders of Tilray Brands, Inc.(1,478,502)(650,233)(214,596)
Non-controlling interests$ 27,146$ 19,367$ 31,407
Weighted average number of common shares - basic (in shares)617,982,589481,219,130269,549,852
Weighted average number of common shares - diluted (in shares)617,982,589481,219,130269,549,852
Net loss per share - basic (in dollars per share)$ (2.35)$ (0.99)$ (1.36)
Net loss per share - diluted (in dollars per share)$ (2.35)$ (0.99)$ (1.36)

TLRY Balance Sheet

2023-05-31
Consolidated Statements of Financial Position - USD ($)
$ in Thousands
May 31, 2023
May 31, 2022
Current assets  
Cash and cash equivalents$ 206,632$ 415,909
Marketable securities241,8970
Accounts receivable, net86,22795,279
Inventory200,551245,529
Prepaids and other current assets37,72246,786
Total current assets773,029803,503
Capital assets429,667587,499
Right-of-use assets5,94112,996
Intangible assets973,7851,277,875
Goodwill2,008,8432,641,305
Interest in equity investees4,5764,952
Long-term investments7,79510,050
Convertible notes receivable103,401111,200
Other assets222314
Total assets4,307,2595,449,694
Current liabilities  
Bank indebtedness23,38118,123
Accounts payable and accrued liabilities190,682157,431
Contingent consideration16,21816,007
Warrant liability1,81714,255
Current portion of lease liabilities2,4236,703
Current portion of long-term debt24,08067,823
Current portion of convertible debentures payable174,3780
Total current liabilities432,979280,342
Long - term liabilities  
Contingent consideration10,8890
Lease liabilities7,93611,329
Long-term debt136,889117,879
Convertible debentures payable221,044401,949
Deferred tax liabilities167,364196,638
Other liabilities215191
Total liabilities977,3161,008,328
Commitments and contingencies (see to Note 27)
Stockholders' equity  
Common stock ($0.0001 par value; 990,000,000 shares authorized; 656,655,455 and 532,674,887 shares issued and outstanding, respectively)6653
Additional paid-in capital5,777,7435,382,367
Accumulated other comprehensive loss(46,610)(20,764)
Accumulated Deficit(2,415,507)(962,851)
Total Tilray Brands, Inc. stockholders' equity3,315,6924,398,805
Non-controlling interests14,25142,561
Total stockholders' equity3,329,9434,441,366
Total liabilities and stockholders' equity$ 4,307,259$ 5,449,694
Irwin D. Simon
2100
Tilray Brands Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. It operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. The company provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. It offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. The company operates Tilray Medical, a medical platform that provides GMP-certified flowers, oils, vapes, edibles, and topicals. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Tilray, Inc. Tilray Brands Inc. was incorporated in 2018 and is headquartered in New York, New York.